Doctors treating cancer can now save time with GE HealthCare's new AI tool.

• Doctors will save time when diagnosing and treating cancer with GE HealthCare's new artificial intelligence application.
• CareIntellect for Oncology is a tool that rapidly summarizes patients' medical histories, tracks disease advancement, and identifies pertinent clinical trials, the company stated.
• GE HealthCare unveiled five AI tools it is currently developing, including an AI agent solution.

On Monday, it was announced that a new artificial intelligence application would be launched, aimed at streamlining the process of diagnosing and treating cancer for doctors, ultimately saving them valuable time.

GE's CareIntellect for Oncology tool streamlines the process of oncologists accessing patient data, allowing them to focus on patient care without being bogged down by record-digging.

The analysis of health-care data is challenging, with up to 97% of hospital-generated data remaining unused, as per a Deloitte report. This information is stored in various vendors and formats, including images, lab test results, clinical notes, and device readings, which can be overwhelming for doctors to manage.

Dr. Taha Kass-Hout, GE HealthCare's global chief science and technology officer, stated in an interview with CNBC that it is both time-consuming and frustrating for these clinicians.

Kass-Hout stated that CareIntellect for Oncology can detect when patients are not adhering to their treatment plans by analyzing clinical reports and flagging any deviations. The system can also notify doctors if a patient misses a lab test, allowing them to take appropriate action.

Numerous doctor visits and a treatment journey that can last years are what cancer patients often have to endure, according to him.

GE HealthCare's CareIntellect for Oncology can streamline the process of identifying relevant clinical trials for patients, saving oncologists time and effort, according to Chelsea Vane, vice president of digital products at GE HealthCare. Traditionally, doctors have had to manually search through a database of available trials, memorize inclusion and exclusion criteria, and sift through patient records to find a suitable match.

"What we've done is remove that," she said.

CareIntellect for Oncology enables oncologists to save time and effort while allowing them to view the original record if they wish to delve deeper into details, the company stated.

GE HealthCare plans to launch CareIntellect for Oncology in the US in 2025, initially focusing on prostate and breast cancers. The tool is already being evaluated by health organizations such as Tampa General Hospital. As a cloud-based solution, it will generate recurring revenue for the company, said Kass-Hout.

Kass-Hout stated that the company plans to launch more apps under the CareIntellect brand in the future, with the oncology tool being the initial offering. Health-care organizations will have the flexibility to select the specific apps they want to implement.

GE HealthCare aims to integrate its CareIntellect products with other early stage AI initiatives it announced on Monday.

The company showcased five AI products in development, including an AI team that works collaboratively, a tool for predicting aggressive breast cancer recurrence, and a tool that quickly flags suspicious mammography scans to radiologists.

Kass-Hout stated that GE HealthCare will present the new tools to customers to demonstrate the issues it aims to address. The company will obtain feedback from healthcare organizations and collaborate with regulators as required.

Health Companion, a tool developed by GE HealthCare, is being used to investigate how a group of AI agents can collaborate to aid doctors in their work.

Kass-Hout stated that the agents in Health Companion will be trained as experts in specific domains, such as radiology, pathology or genomics, and offer insights based on their expertise. These agents could identify whether a specific symptom is a side effect of treatment or a sign of disease progression, for example, and suggest next steps.

Health Companion would provide doctors with the same level of support as working with a multidisciplinary team, said Kass-Hout. However, consulting a panel of experts can take days or weeks, whereas Health Companion would be accessible immediately.

"Currently, it's a preliminary idea," he stated. "Our objective is to enhance the level of care and surpass the strain on clinicians managing their patients."

WATCH: The Pulse of AI in Health Care